West Virginia University Logo

Disease Site: Gynecologic Cancers

2 protocol(s) meet the specified criteria

  • EAY131Molecular Analysis for Therapy Choice (MATCH)
  • RRX001-211-01A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Lung Cancer, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Readministration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)